TFP Group's IPO: Underwriting Risk It Doesn't Have to Hold
TFP Group, the world's largest independent MGA, filed for an NYSE IPO. Its prospectus shows how much still rides on one old affiliate.
Most of the insurance companies that go public own the risk they underwrite — they hold capital reserves against the policies they write, and their stock price moves with loss ratios and catastrophe exposure. TFP Group, which publicly filed an F-1 with the SEC on September 25, 2026 to list on the NYSE under the ticker TFP, is a different kind of insurance business entirely. It's one of more than 60 names still working through Zorro's IPO pipeline, and it's worth a closer look precisely because it doesn't fit the pattern most insurance IPOs do.
A business that places risk, not a business that holds it
TFP Group — operating as The Fidelis Partnership, founded and still led by chairman and group CEO Richard Brindle — describes itself as the world's largest independent managing general agent, a type of firm that originates and underwrites insurance and reinsurance on behalf of capacity providers rather than carrying that risk on its own balance sheet. In practice, that means TFP's underwriters assess a risk, price it, and bind coverage, but the capital actually standing behind the policy sits with a separate carrier that pays TFP a fee and a share of profits for the underwriting work. The company does this across more than 150 specialty and bespoke lines in over 140 countries, and wrote $5.39 billion of premium on behalf of its capacity providers in 2025, up from $4.66 billion in 2024.
That fee-based, asset-light structure is the entire investment thesis in one sentence: TFP is a people-and-underwriting-discipline business wrapped in an insurance ticker, not a balance-sheet business. It's a meaningfully different animal from the carriers it's sometimes grouped with on a public-markets watchlist, including Arch Capital Group and RenaissanceRe, both of which hold underwriting risk directly on their own books.
The number that matters more than the raise
TFP is targeting an estimated $350 million raise, modest next to some of the names sharing the pipeline this month, and bankers have floated a valuation in the $2–3.5 billion range. But the more informative figures sit inside the financial statements: TFP booked $723 million in revenue for the twelve months ended June 30, 2026, and for the six months ended that date alone reported $407.5 million in revenue against $127.5 million in net income — a profit margin north of 30% on revenue, consistent with a fee-driven underwriting-services business rather than a capital-intensive carrier. Underwriters on the deal include Morgan Stanley, Barclays and JPMorgan.
Where the real risk factor lives
TFP was spun out of Fidelis Insurance Holdings in 2023, and the carrier side of that original business — the balance sheet that actually holds much of the risk TFP originates — now operates separately as Pelagos Insurance Capital. The two companies share history, not ownership, but TFP's prospectus discloses a 10-year rolling binder agreement that still routes a large share of the business TFP underwrites to Pelagos as its anchor capacity provider. That's the kind of disclosure a prospectus's risk-factors section exists to surface: TFP's revenue depends on capacity providers actually accepting the risk it places, and its single largest capacity relationship runs through a company it no longer owns or controls. A fee-based model solves the balance-sheet risk a traditional carrier carries, but it replaces it with counterparty-concentration risk — if Pelagos's own capital position or appetite for TFP-originated business ever changed, a meaningful share of TFP's premium volume would need a new home.
Blackstone is the other name that recurs throughout TFP's recent history. The private-equity firm is both a TFP shareholder and a strategic capital partner, having backed a 2024 refinancing and equity investment, and it separately committed dedicated three-year capital to Syndicate 2126, a new Lloyd's syndicate TFP launched in October 2025 that writes property, specialty and bespoke lines — including through TFP's own Pine Walk MGA platform — as well as reinsurance of existing group business. That syndicate is itself a hedge against the Pelagos concentration: a second, TFP-controlled source of underwriting capacity that doesn't depend on the original sister company's balance sheet.
What this IPO is actually testing
Specialty insurance and reinsurance aren't glamorous sectors, but they're exactly the kind of business a managing general agent model is built for — risk that's bespoke enough, and underwriting expertise specific enough, that capacity providers would rather pay a skilled originator a fee than build that underwriting capability themselves. TFP's pitch to public investors is that it has built the largest independent version of that business, with growing premium volume and a profit margin that looks more like a services company's than an insurer's. Its own numbers, once the offering is priced, will land on Zorro's recent-IPO tracker alongside the rest of this month's specialty-finance debuts. What a public market will have to decide is whether a fee-based underwriter without its own balance sheet deserves the valuation multiple of a business that takes on risk directly — or whether the Pelagos concentration disclosed in its own prospectus means it should trade at a discount to one.